News

KMT will become a subsidiary of PhoenixBio group effective November 30, 2017. PhoenixBio plans to invest in KMT and expand its operations. The uPA/SCID mouse model with a

Guselkumab is the first biologic that selectively blocks interleukin (IL)-23, a key driver of the immune inflammatory response in psoriasis. "We are delighted guselkumab will now be available

The trial, dubbed WISTERIA, will assess the effectiveness of the pharma company’s experimental compound AZD1775, in combination with chemotherapy prior to surgery or with chemotherapy and radiotherapy after surgery.

The VITALITY-ALS (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices after Treatment for a Year in ALS) is a phase 3 clinical trial of tirasemtiv in patients

The company received formal notification from AEMPS for an extension to its licence 6458E: Manufacturer of Investigational Medicinal Products, to include the manufacture of monodispersed controlled release microcapsules,

Through the study, it was discovered that people who used lansoprazole, a widely used gastric acid suppressant were a third less likely to get TB, as opposed to

People in France, the Netherlands, Spain, Sweden, Switzerland and UK can now take part in the study, which aims to develop tests to identify early signs of Alzheimer’s

Juluca is said to be the first 2DR, which includes dolutegravir 50mg produced by ViiV Healthcare and rilpivirine 25mg produced by Janssen Therapeutics. Dolutegravir 50mg is an integrase

Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, will expand its manufacturing operations in Wilson County, Governor